Results
1 -
10 of
22
(Click
here to explore results)
Epigenetics for Drug Discovery, CHAPTER 7 Targeting Non-Acetylation Histone Erasers . Fei Lu, Hui Zhang
, 2016
, Pages 168-191
Biomedical Imaging: The Chemistry of Labels, Probes and Contrast Agents, Chapter 3 Recent Developments in PET and SPECT Radioligands for CNS Imaging . David Alagille, Ronald M. Baldwin, Gilles D. Tamagnan
, 2012
, Pages 49-143
Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and other Xenobiotics, Chapter 5 The CYP2A Subfamily . Hannu Raunio, Jukka Hakkola, Olavi Pelkonen
, 2008
, Pages 150-177
Electrochemical Detection in HPLC: Analysis of Drugs and Poisons, Applications of HPLC-ED in the analysis of drugs . Roger M. Smith, Robert J. Flanagan, David Perrett, Robin Whelpton
, 2005
, Pages 104-210
Drug Discovery for Psychiatric Disorders, CHAPTER 3 Monoaminergic Approaches for Treatment of Schizophrenia . David P. Rotella
, 2012
, Pages 35-55
Fragment-Based Drug Discovery, CHAPTER 10 Fragment-Based Approaches to Epigenetic Targets . Chun-wa Chung, Paul Bamborough
, 2015
, Pages 238-258
New Horizons in Predictive Toxicology: Current Status and Application, Chapter 10 Human-based In Vitro Experimental Systems for the Assessment of Human-Specific Adverse Drug Effects: Scientific Concepts, Current Applications and Promising Approaches . Albert P. Li
, 2012
, Pages 221-248
New Frontiers in Chemical Biology: Enabling Drug Discovery, Chapter 4 Chemical Biology of Stem Cell Modulation . Stephen G. Davies, Angela J. Russell
, 2011
, Pages 97-150
Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 4 Primary, Secondary and Tertiary Amines and their Isosteres . D. K. Walker, R. M. Jones, A. N. R. Nedderman, P. A. Wright
, 2010
, Pages 168-209
New Frontiers in Chemical Biology: Enabling Drug Discovery, Chapter 5 Chemical Biology of Histone Modifications . Nathan R. Rose, Christopher J. Schofield, Tom D. Heightman
, 2011
, Pages 151-203